Product Information
AMOXICILLIN 875 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1536 per EA under NDC 57237002920. Its NADAC has been published 570 times since Nov 4, 2015.
FDA first approved this application on Nov 9, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
875 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237002920
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLINApproval Type
Generic (ANDA)
FDA Application
ANDA065256FDA Approved
11/9/2005
TE Code
AB
On Market Since
11/9/2005
Pharmacological Classes
Price Statistics
The NADAC for AMOXICILLIN 875 MG TABLET has been published 570 times since Nov 4, 2015, and over the history we have for it it has risen 17.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1536 per EA |
|---|---|
| All-time high | $0.1971 (Feb 14, 2024) |
| All-time low | $0.1173 (Sep 19, 2018) |
| 52-week high | $0.1655 |
| 52-week low | $0.1520 |
| Median price | $0.1431 |
| Average price | $0.1480 |
| Largest weekly change | +28.8% (Jan 20, 2016) |
| Weeks tracked | 570 |
| Tracking since | Nov 4, 2015 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOXICILLIN 875 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMOXICILLIN 875 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1536 per EA (NDC 57237002920), effective Sep 30, 2026.
How has the price of AMOXICILLIN 875 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMOXICILLIN 875 MG TABLET has risen 17.3%. It has been tracked across 570 weekly CMS publications since Nov 4, 2015.
What are the highest and lowest recorded NADAC prices for AMOXICILLIN 875 MG TABLET?
Since Nov 4, 2015, the NADAC for AMOXICILLIN 875 MG TABLET has ranged from a low of $0.1173 (Sep 19, 2018) to a high of $0.1971 (Feb 14, 2024), with a median of $0.1431 per EA.
Are there cheaper alternatives to AMOXICILLIN 875 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMOXICILLIN 875 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AMOXICILLIN 875 MG TABLET?
AMOXICILLIN 875 MG TABLET (NDC 57237002920) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.